Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Health In Tech, Inc.HIT · Entity 7078 | Chief Growth Officer | September 15, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Health In Tech, Inc.
Report date September 15, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 183,749 |
Reported balance
After 2026-09-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-15 · Tax withholding · Disposed 4,795 · Balance 183,749 F1: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4. F2: Includes 168,538 restricted shares of Class A Common Stock and 15,211 unrestricted shares of Class A Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.
F2: Includes 168,538 restricted shares of Class A Common Stock and 15,211 unrestricted shares of Class A Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 16, 2026 21:21 UTC | Health In Tech, Inc. HIT · Entity 7078 | Tax withholdingClass A Common Stock | 4,795 | $0.89 | $4,267.55 |
DisclosureSEC source: 0001213900-26-100594 · ownership.xml · nonDerivative · entry 1 Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,749 F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4. F2 · balance_after: Includes 168,538 restricted shares of Class A Common Stock and 15,211 unrestricted shares of Class A Common Stock. Read SEC document |
| September 11, 2026 Filed Sep 14, 2026 12:55 UTC | Health In Tech, Inc. HIT · Entity 7078 | SaleClass A Common Stock | 11,667 | $0.92 | $10,733.64 |
DisclosureSEC source: 0001213900-26-099471 · ownership.xml · nonDerivative · entry 1 Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 188,544 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2026. F2 · balance_after: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.9103 to $0.9541 per share, inclusive. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 13, 2026 Filed Aug 17, 2026 20:30 UTC | Health In Tech, Inc. HIT · Entity 7078 | Tax withholdingClass A Common Stock | 4,007 | $1.06 | $4,247.42 |
DisclosureSEC source: 0001213900-26-090790 · ownership.xml · nonDerivative · entry 1 Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,211 F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4. F2 · balance_after: Includes 179,326 restricted shares of Class A Common Stock and 20,885 unrestricted shares of Class A Common Stock. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 22:52 UTC | Health In Tech, Inc. HIT · Entity 7078 | Tax withholdingClass A Common Stock | 4,084 | $1.04 | $4,247.36 |
DisclosureSEC source: 0001213900-26-079326 · ownership.xml · nonDerivative · entry 1 Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,218 F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4. F2 · balance_after: Includes 189,249 restricted shares of Class A Common Stock and 14,969 unrestricted shares of Class A Common Stock. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 12:55 UTC | Health In Tech, Inc. HIT · Entity 7078 | Tax withholdingClass A Common Stock | 4,045 | $1.05 | $4,247.25 |
DisclosureSEC source: 0001213900-26-069895 · ownership.xml · nonDerivative · entry 1 Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,302 F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4. F2 · balance_after: Includes 199,288 restricted shares of Class A Common Stock and 9,014 unrestricted shares of Class A Common Stock. Read SEC document |
| May 14, 2026 Filed May 18, 2026 21:23 UTC | Health In Tech, Inc. HIT · Entity 7078 | Tax withholdingClass A Common Stock | 4,205 | $1.23 | $5,172.15 |
DisclosureSEC source: 0001213900-26-058564 · ownership.xml · nonDerivative · entry 1 Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,347 F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4. F2 · balance_after: Includes 205,680 restricted shares of Class A Common Stock and 6,667 unrestricted shares of Class A Common Stock. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 20:50 UTC | Health In Tech, Inc. HIT · Entity 7078 | Tax withholdingClass A Common Stock | 3,448 | $1.50 | $5,172.00 |
DisclosureSEC source: 0001213900-26-045214 · ownership.xml · nonDerivative · entry 1 Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,552 F1 · shares: Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4 filed on January 8, 2026. F2 · balance_after: Includes 211,552 restricted shares of Class A Common Stock and 5,000 unrestricted shares of Class A Common Stock. Read SEC document |
| January 06, 2026 Filed Jan 9, 2026 02:27 UTC | Health In Tech, Inc. HIT · Entity 7078 | GrantClass A Common Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-002660 · ownership.xml · nonDerivative · entry 1 Hasan Zain Syed · CIK 0002102674 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,000 F1 · shares: Represents restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan in connection with two proposed issuer transactions (each, a "Transaction"). Half of the shares vest in equal monthly installments over 12 months starting at the closing of the first Transaction ("First Transaction Shares"). The other half vest in equal monthly installments over 12 months starting at the closing of the second Transaction ("Second Transaction Shares"). Vesting is subject to continued service. If either Transaction does not close within 24 months after January 6, 2026 (the "Grant Date"), unvested shares relating to that Transaction will be automatically forfeited without consideration. F2 · balance_after: Includes 220,000 shares of restricted shares of Class A Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.